These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


698 related items for PubMed ID: 15824066

  • 1. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J, Luscher MA, Xiong Y, Rustam T, Amara RR, Rakasz E, Robinson HL, MacDonald KS.
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
    Allen TM, Sidney J, del Guercio MF, Glickman RL, Lensmeyer GL, Wiebe DA, DeMars R, Pauza CD, Johnson RP, Sette A, Watkins DI.
    J Immunol; 1998 Jun 15; 160(12):6062-71. PubMed ID: 9637523
    [Abstract] [Full Text] [Related]

  • 3. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.
    J Virol; 2005 Oct 15; 79(19):12321-31. PubMed ID: 16160159
    [Abstract] [Full Text] [Related]

  • 4. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques.
    Nakamura M, Takahara Y, Ishii H, Sakawaki H, Horiike M, Miura T, Igarashi T, Naruse TK, Kimura A, Matano T, Matsuoka S.
    Microbiol Immunol; 2011 Nov 15; 55(11):768-73. PubMed ID: 21895748
    [Abstract] [Full Text] [Related]

  • 5. Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.
    Donahoe SM, Moretto WJ, Samuel RV, Metzner KJ, Marx PA, Hanke T, Connor RI, Nixon DF.
    Virology; 2000 Jul 05; 272(2):347-56. PubMed ID: 10873778
    [Abstract] [Full Text] [Related]

  • 6. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC, Dunham RM, Makedonas G, Vanderford TH, Sumpter B, Klatt NR, Ratcliffe SJ, Garg S, Paiardini M, McQuoid M, Altman JD, Staprans SI, Betts MR, Garber DA, Feinberg MB, Silvestri G.
    J Immunol; 2009 Jul 01; 183(1):706-17. PubMed ID: 19542473
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.
    Couillin I, Letourneur F, Lefèbvre P, Guillet JG, Martinon F.
    Virology; 2001 Jan 05; 279(1):136-45. PubMed ID: 11145897
    [Abstract] [Full Text] [Related]

  • 9. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N, Patterson LJ, Aldrich K, Richardson E, Alvord WG, Robert-Guroff M.
    J Immunol; 2003 Apr 15; 170(8):4281-9. PubMed ID: 12682263
    [Abstract] [Full Text] [Related]

  • 10. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
    Kawada M, Igarashi H, Takeda A, Tsukamoto T, Yamamoto H, Dohki S, Takiguchi M, Matano T.
    J Virol; 2006 Feb 15; 80(4):1949-58. PubMed ID: 16439550
    [Abstract] [Full Text] [Related]

  • 11. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
    Takahara Y, Matsuoka S, Kuwano T, Tsukamoto T, Yamamoto H, Ishii H, Nakasone T, Takeda A, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Sakawaki H, Horiike M, Miura T, Igarashi T, Naruse TK, Kimura A, Matano T.
    Biochem Biophys Res Commun; 2011 May 20; 408(4):615-9. PubMed ID: 21531211
    [Abstract] [Full Text] [Related]

  • 12. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.
    Newberg MH, Kuroda MJ, Charini WA, Miura A, Lord CI, Schmitz JE, Gorgone DA, Lifton MA, Kuus-Reichel K, Letvin NL.
    Virology; 2002 Sep 30; 301(2):365-73. PubMed ID: 12359438
    [Abstract] [Full Text] [Related]

  • 13. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
    Letvin NL, Miller MD, Shen L, Chen ZW, Yasutomi Y.
    Semin Immunol; 1993 Jun 30; 5(3):215-23. PubMed ID: 8394161
    [Abstract] [Full Text] [Related]

  • 14. Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay.
    Vogel T, Norley S, Beer B, Kurth R.
    Immunology; 1995 Mar 30; 84(3):482-7. PubMed ID: 7751033
    [Abstract] [Full Text] [Related]

  • 15. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
    Vogel TU, Friedrich TC, O'Connor DH, Rehrauer W, Dodds EJ, Hickman H, Hildebrand W, Sidney J, Sette A, Hughes A, Horton H, Vielhuber K, Rudersdorf R, De Souza IP, Reynolds MR, Allen TM, Wilson N, Watkins DI.
    J Virol; 2002 Nov 30; 76(22):11623-36. PubMed ID: 12388723
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.
    Venet A, Bourgault I, Aubertin AM, Kiény MP, Levy JP.
    J Immunol; 1992 May 01; 148(9):2899-908. PubMed ID: 1349322
    [Abstract] [Full Text] [Related]

  • 17. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
    Loffredo JT, Sidney J, Wojewoda C, Dodds E, Reynolds MR, Napoé G, Mothé BR, O'Connor DH, Wilson NA, Watkins DI, Sette A.
    J Immunol; 2004 Oct 15; 173(8):5064-76. PubMed ID: 15470050
    [Abstract] [Full Text] [Related]

  • 18. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa.
    Murphey-Corb M, Wilson LA, Trichel AM, Roberts DE, Xu K, Ohkawa S, Woodson B, Bohm R, Blanchard J.
    J Immunol; 1999 Jan 01; 162(1):540-9. PubMed ID: 9886431
    [Abstract] [Full Text] [Related]

  • 19. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F, Brochard P, Ripaux M, Delache B, Aurégan G, Vaslin B, Le Grand R.
    Vaccine; 2008 Jan 24; 26(4):532-45. PubMed ID: 18093703
    [Abstract] [Full Text] [Related]

  • 20. A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys.
    Yasutomi Y, McAdam SN, Boyson JE, Piekarczyk MS, Watkins DI, Letvin NL.
    J Immunol; 1995 Mar 01; 154(5):2516-22. PubMed ID: 7532670
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.